Cite
HARVARD Citation
Wei, L. et al. (2019). Sofosbuvir–velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial. Lancet gastroenterology and hepatology. pp. 127-134. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wei, L. et al. (2019). Sofosbuvir–velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial. Lancet gastroenterology and hepatology. pp. 127-134. [Online].